Literature DB >> 31260219

RED PANDAS' (AILURUS FULGENS) SEROLOGICAL RESPONSE TO CANARYPOX-VECTORED CANINE DISTEMPER VACCINES.

Edward C Ramsay1, Timothy A Georoff2, Caitlin Burrell3, Eman Anis4,5, Rebecca P Wilkes5.   

Abstract

Red pandas (Ailurus fulgens) are susceptible to canine distemper, with a number of reported vaccine-induced canine distemper cases. Canarypox-vectored recombinant canine distemper vaccines (PureVax Ferret Distemper [PFD] and Recombitek CDV [rCDV]) provide protection without inoculating a live distemper virus, but there are currently no published data regarding these vaccines' safety and efficacy in red pandas. One hundred twenty-two serum samples were collected from 50 captive red pandas and analyzed for antibodies to canine distemper. All naïve red pandas (n = 20) had negative titers. Naïve pandas receiving two PFD vaccinations had either negative or intermediate titers (n = 4). In contrast, naïve pandas receiving a series of two or three rCDV vaccinations (n = 14) had greater antibody responses. Red pandas vaccinated with PFD >12 mo since their last vaccination and a rCDV booster vaccination showed the highest titers observed. We recommend red pandas be administered a series of at least three recombinant vaccine (PDF or rDCV) vaccinations, followed by annual booster vaccinations. Copyright 2019 by American Association of Zoo Veterinarians.

Entities:  

Keywords:  Ailurus fulgens fulgens; Ailurus fulgens refulgens; canarypox-vectored; canine distemper; red panda; serology; vaccination

Mesh:

Substances:

Year:  2019        PMID: 31260219     DOI: 10.1638/2018-0160

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  1 in total

1.  Canine distemper in Nepal's Annapurna Conservation Area - Implications of dog husbandry and human behaviour for wildlife disease.

Authors:  Debby Ng; Scott Carver; Mukhiya Gotame; Dibesh Karmasharya; Dikpal Karmacharya; Saman Man Pradhan; Ajay Narsingh Rana; Christopher N Johnson
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.